ConductScience.org, home

Paper21391893

Harm reduction and 12 steps: complementary, oppositional, or something in-between?

Lee HS and 2 others. Subst Use Misuse, 2011. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Harm reduction and 12 steps: complementary, oppositional, or something in-between? Papers, record 21391893. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21391893

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Harm reduction and 12 steps: complementary, oppositional, or something in-between?
PubMed
Journal
Subst Use Misuse
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.59
iCite
Revised in PubMed
2011-06-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee HSHeather Sophia
2Engstrom MMalitta
3Petersen SRScott R

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
RehabilitationMajor topic
Risk Reduction BehaviorMajor topic
Substance Abuse, IntravenousMajor topic
Adult
Alcoholics Anonymous
Female
HIV Infections
Humans
Interviews as Topic
Male

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2 T01 CD000189-01ODCDC CDC HHSUnited StatesT01CD000189PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41512305Latent Classes of Substance Use in Young Adult Survivors of Child Maltreatment and Adversity: A 20-Year Prospective Investigation.Child Maltreat2026https://conductscience.org/library/papers/41512305PubMed
40255053Mapping the Landscape: A Scoping Review of Evaluated Substance Use Harm Reduction Programs for Youth.J Drug Educ2025https://conductscience.org/library/papers/40255053PubMed
39215391Ethical Issues in Treating Substance Use Disorders: Counselor Perspectives.J Psychoactive Drugs2025https://conductscience.org/library/papers/39215391PubMed
39210459A qualitative exploration of harm reduction in practice by street-based peer outreach workers.Harm Reduct J2024https://conductscience.org/library/papers/39210459PubMed
38991914Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl.Vaccine2024https://conductscience.org/library/papers/38991914PubMed
38718060A survey of educator perspectives toward teaching harm reduction cannabis education.PLoS One2024https://conductscience.org/library/papers/38718060PubMed
36429926
The Potential for Managed Alcohol Programmes in Scotland during the COVID-19 Pandemic: A Qualitative Exploration of Key Areas for Implementation Using the Consolidated Framework for Implementation Research.
Int J Environ Res Public Health2022https://conductscience.org/library/papers/36429926PubMed
35212621A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.Health Technol Assess2022https://conductscience.org/library/papers/35212621PubMed
32005119What constitutes effective problematic substance use treatment from the perspective of people who are homeless? A systematic review and meta-ethnography.Harm Reduct J2020https://conductscience.org/library/papers/32005119PubMed
24359089A home for body and soul: substance using women in recovery.Harm Reduct J2013https://conductscience.org/library/papers/24359089PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21391893

GET https://conductscience.org/api/papers/v1/21391893/authors